|

GDC-6988 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: RO7506811

Pipeline

Phase 1/2: 1

Top Sponsors

  • Genentech, Inc.1

Indications

  • Non-cystic Fibrosis Bronchiectasis1
  • Chronic Obstructive Pulmonary Disease1
  • COPD1

Birmingham, Alabama1 trial

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

University of Alabama at Birmingham

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.